GlassScriptPhysician profile
Sarah Baker
NPI 1447764758
$4,544.68
in general payments reported to CMS, 2019-2025
17 companies · $770 in 2025
The $770 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $651 · 2022: $2,276 · 2023: $848 · 2025: $770.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,332 · Travel and Lodging: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,332.13 |
| Travel and Lodging | $285.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,022.01 | 2021-2025 | Aveir, Cardiomems, Amplatzer Amulet |
| Medtronic, INC. | $1,690.84 | 2021-2023 | Micra, Azure Xt Dr Mri Surescan |
| E.R. Squibb & Sons, L.L.C. | $202.03 | 2021-2025 | Camzyos |
| Cvrx, INC. | $171.37 | 2025 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $113.00 | 2021-2025 | |
| Pfizer INC. | $102.10 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $43.62 | 2021-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $37.11 | 2021 | |
| Impulse Dynamics (USA) INC. | $29.31 | 2023 | Optimizer |
| Astrazeneca Pharmaceuticals LP | $22.60 | 2025 | Wainua |
| Heartflow, INC. | $20.17 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.34 | 2025 | Jardiance |
| Esperion Therapeutics, INC. | $15.73 | 2021 | |
| Philips North America LLC | $15.70 | 2022 | |
| Sanofi-Aventis U.S. LLC | $15.39 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $15.14 | 2023 | Phasix Mesh |
| Amgen INC. | $11.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.